Published in Circulation on March 26, 2009
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell (2013) 6.35
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail (2010) 3.01
Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol (2012) 2.98
Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol (2013) 2.89
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Heart failure: epidemiology and prevention in India. Natl Med J India (2011) 2.09
Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study. Circ Heart Fail (2015) 2.02
Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction. Circulation (2015) 2.02
Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation (2011) 2.00
Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail (2011) 1.99
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
Myocarditis: early biopsy allows for tailored regenerative treatment. Dtsch Arztebl Int (2012) 1.88
Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes (2011) 1.88
Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation (2011) 1.78
Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol (2010) 1.77
Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation (2010) 1.73
Automated extraction of ejection fraction for quality measurement using regular expressions in Unstructured Information Management Architecture (UIMA) for heart failure. J Am Med Inform Assoc (2012) 1.72
Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol (2011) 1.69
Digoxin associates with mortality in ESRD. J Am Soc Nephrol (2010) 1.66
Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging (2012) 1.65
Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure. Circ Heart Fail (2012) 1.62
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. Am J Med (2013) 1.61
Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail (2010) 1.55
Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. Ann Thorac Surg (2012) 1.54
Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study. Ann Intern Med (2016) 1.54
Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J (2012) 1.53
Using methods from the data-mining and machine-learning literature for disease classification and prediction: a case study examining classification of heart failure subtypes. J Clin Epidemiol (2013) 1.50
What strategies are effective for exercise adherence in heart failure? A systematic review of controlled studies. Heart Fail Rev (2012) 1.49
Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation (2013) 1.48
Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project. Am Heart J (2016) 1.47
Quality of care for heart failure patients hospitalized for any cause. J Am Coll Cardiol (2013) 1.46
Medication adherence: emerging use of technology. Curr Opin Cardiol (2011) 1.44
Translating and testing the ENABLE: CHF-PC concurrent palliative care model for older adults with heart failure and their family caregivers. J Palliat Med (2014) 1.41
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol (2010) 1.39
Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer (2010) 1.38
Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail (2012) 1.35
GRK2 as a novel gene therapy target in heart failure. J Mol Cell Cardiol (2010) 1.31
N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail (2012) 1.31
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest (2011) 1.26
Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure. J Mol Cell Cardiol (2010) 1.23
Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease. Am J Med (2012) 1.22
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Eur J Heart Fail (2011) 1.20
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors. Oncologist (2013) 1.19
Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol (2010) 1.19
Three gram sodium intake is associated with longer event-free survival only in patients with advanced heart failure. J Card Fail (2011) 1.17
Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging (2010) 1.14
Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results. Acta Myol (2012) 1.14
Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011. Open Heart (2014) 1.14
Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Heart Fail Rev (2012) 1.14
The early origins of chronic heart failure: impaired placental growth and initiation of insulin resistance in childhood. Eur J Heart Fail (2010) 1.13
Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis. PLoS One (2014) 1.11
Advance directives in community patients with heart failure. Circ Cardiovasc Qual Outcomes (2012) 1.10
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur J Heart Fail (2013) 1.06
Exercise training restores cardiac protein quality control in heart failure. PLoS One (2012) 1.06
Peripartum cardiomyopathy: a review. Tex Heart Inst J (2012) 1.06
The disconnect between phase II and phase III trials of drugs for heart failure. Nat Rev Cardiol (2013) 1.03
Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am J Med (2013) 1.03
Giving voice to patients' and family caregivers' needs in chronic heart failure: implications for palliative care programs. J Palliat Med (2011) 1.03
Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J Am Soc Nephrol (2014) 1.02
Novel wireless devices for cardiac monitoring. Circulation (2014) 1.02
Computational models reduce complexity and accelerate insight into cardiac signaling networks. Circ Res (2011) 1.00
Improved survival after heart failure: a community-based perspective. J Am Heart Assoc (2013) 1.00
Methamphetamine-associated cardiomyopathy. Clin Cardiol (2013) 0.99
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol (2015) 0.99
Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship. J Clin Oncol (2012) 0.97
Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study. JACC Heart Fail (2013) 0.95
Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Fail Rev (2014) 0.95
The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type. J Med Econ (2012) 0.95
Heart failure with preserved ejection fraction. Glob Cardiol Sci Pract (2012) 0.94
Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med (2013) 0.93
Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev (2013) 0.93
Rationale, Design, Methodology and Hospital Characteristics of the First Gulf Acute Heart Failure Registry (Gulf CARE). Heart Views (2014) 0.93
Cardiorenal syndrome: ultrafiltration therapy for heart failure--trials and tribulations. Clin J Am Soc Nephrol (2013) 0.93
Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. Am Heart J (2012) 0.93
Clinical outcome and cost-effectiveness of a synchronous telehealth service for seniors and nonseniors with cardiovascular diseases: quasi-experimental study. J Med Internet Res (2013) 0.93
ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy. Stem Cells (2010) 0.93
Anticoagulation in heart failure: current status and future direction. Heart Fail Rev (2013) 0.93
Preoperative medical evaluation: part 1: general principles and cardiovascular considerations. Anesth Prog (2009) 0.93
I -123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients. J Biomed Res (2013) 0.92
Self-rated health predicts healthcare utilization in heart failure. J Am Heart Assoc (2014) 0.92
Acute decompensated heart failure is routinely treated as a cardiopulmonary syndrome. PLoS One (2013) 0.92
Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies. Am Heart J (2012) 0.92
Current perspectives on combination therapy in the management of hypertension. Integr Blood Press Control (2013) 0.92
Regulation of the cardiac sodium pump. Cell Mol Life Sci (2012) 0.92
Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction. Am J Med (2013) 0.92
Recent trends in the characteristics and prognosis of patients hospitalized with acute heart failure. Clin Epidemiol (2011) 0.91
Determinants of adherence to heart failure medication: a systematic literature review. Heart Fail Rev (2013) 0.91
N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients. AIDS (2011) 0.91
Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS Negl Trop Dis (2010) 0.91
Determinants of heart failure self-care: a systematic literature review. Heart Fail Rev (2012) 0.90
Palliative care consultations for heart failure patients: how many, when, and why? J Card Fail (2013) 0.90
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev (2013) 0.90
Pathological ventricular remodeling: therapies: part 2 of 2. Circulation (2013) 0.90
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med (2004) 18.38
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med (2005) 15.46
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med (2013) 7.35
Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation (2008) 7.11
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Religion, conscience, and controversial clinical practices. N Engl J Med (2007) 6.67
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA (2005) 6.32
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg (2007) 6.08
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol (2009) 5.76
The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial. Ann Intern Med (2006) 5.47
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics (2011) 5.46
Is it important to examine gender differences in the epidemiology and outcome of severe heart failure? J Thorac Cardiovasc Surg (2004) 5.35
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA (2003) 5.30
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol (2008) 5.09
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation (2007) 4.67
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med (2003) 4.61
Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA (2007) 4.59
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J (2006) 4.55
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA (2007) 4.30
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA (2006) 4.30
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol (2005) 4.26